EU Agency Recommends Against Extended Use of Sanofi-Aventis (France)'s Taxotere

July 25, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, July 25 (Reuters) - The European Medicines Agency has recommended against extended use of Sanofi Aventis' drug Taxotere to treat HER2 positive breast cancer, the London-based watchdog said on Friday.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Europe

Sanofi (France)